Summary
In a group of 20 homozygous (SS) sickle cell patients (age range 8·28 years) determinations of red blood cell and platelet calcium as well as platelet aggregation and platelet malondialdehyde formation were performed before and after oral treatment with 28.4 mg/kg daily pentoxifylline (Trental®) for 30 days. After a previous observation period, drug treatment was started at the onset of painful exacerbation, which thereby subsided within 26.4±9.6h; no further pain symptoms were observed during the treatment. All the above mentioned parameters were found to be increased before treatment when compared to normal subjects and they fell progressively during treatment: red blood cell calcium 86.0±17.9 µmol/l (before), 45.0±8.2 µmol/1 (after); intraplatelet calcium 31.6±10.5 µmol/109 platelets (before), 18.0±5.2 µmol/109 platelets (after); malondialdehyde 18.6±8.9 µmol/109 platelets (before), 9.3±3.9 µmol/109 platelets (after). Also platelet aggregation index was significantly reduced. It is concluded that clinical improvement of patients was attributable to the effects of pentoxifylline on both red blood cells and platelets.
Similar content being viewed by others
References
Ambrus J. I., Ambrus C. M., Gastpar H., Bannerman R., Bettigole R., Friedman S.: Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline — J. Med.10, 445, 1979.
De Haas H. A., Clark S. E., Zahavi J., Kakkar V. V., White A. M.: A modified nonradioisotope method for measurement of platelet production time — Brit. J. Haematol.43, 137, 1979.
Detwiller T. C., Charo I. F., Feinman R. D.: Evidence that calcium regulates platelet function — Thrombos. Haemost.40, 207, 1978.
Eaton J. W., Skelton T. D., Swofford H. S., Kolpin C. E., Jacobs H. S.: Elevated erythrocyte calcium in sickle cell disease — Nature (Lond.)246, 105, 1973.
Heilmann E., Laage H. M., Zimmermann E.: Therapeutic influence on flexibility of erythrocytes in sickle cell anaemia — Inn. Med.9, 277, 1982.
Heptinstall S.: The use of a chelating ion-exchange resin to evaluate the effects of the extracellular calcium concentrations on ADP-induced aggregation of human blood platelets — Thrombos. Haemost.36, 208, 1976.
Keller F., Leonhardt H.: Amelioration of blood viscosity in sickle cell anaemia by pentoxifylline: a case report — J. Med.10, 429, 1979.
Manrique R.: Platelet antiaggregants. In:Sousa J. E., Gizzi J. C., Jatene A. D. (Eds): IV Int. Symp. on Coronary Atherosclerosis. São Paulo, April 13–15, 1979.
Manrique R.: The treatment of primary sickle cell crisis with pentoxifylline. In: 6th Meet. Int. Soc. Haematology, European and African Division. Athens, August 30–September 4, 1981. (Abstract).
Manrique R.: Unpublished data.
Massini P., Kaesser-Glanzmann R., Luscher E. F.: Movement of calcium ions and their role in the activation of platelets — Thrombos. Haemost.40, 212, 1978.
Okuma M., Steiner M., Baldin M.: Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody — J. Lab. clin. Med.77, 728, 1971.
Palex J., Liu S.: Membrane protein organisation in ATP-depleted and irreversibly sickled red cells — J. supramolec. Struct.10, 79, 1978.
Seiffge D., Berthold R., Berthold F.: Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results — Klin. Wschr.61, 1159, 1983.
Seiffge D., Kremer E.: Antithrombotic effect of pentoxifylline on laser-induced thrombi in rat mesenteric arteries — IRCS med. Sci.12, 1271, 1984.
Weed R. I., La Celle P. L., Merrill E. W., Craib G., Gregory A., Karch F., Pickens F.: Metabolic dependence of red cell deformability — J. clin. Invest.48, 795, 1969.
Weed R., La Celle P., Udkow M.: Structure and function of the red cell membrane. In:Greewald T. J., Jamieson G. A. (Eds): The red cellin vitro. Grune and Stratton, New York, 1973.
Weithmann K. U.: The influence of pentoxifylline on interaction between blood vessel wall and platelets — IRCS med. Sci.8, 293, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manrique, R. Sickle cell anemia. Pathophysiological role of increased intracorpuscular calcium and changes during treatment with pentoxifylline. La Ricerca Clin. Lab. 17, 355–362 (1987). https://doi.org/10.1007/BF02886919
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02886919